Top Story

Glycemic index did not affect CV risk factors, insulin resistance

December 16, 2014

Diets containing foods with low glycemic index of dietary carbohydrate did not help patients with obesity or overweight achieve better insulin sensitivity, lipid levels or systolic blood pressure, according to research published in JAMA.

Choosing specific foods based on glycemic index may not improve cardiovascular risk factors or insulin resistance in the context of eating patterns established in the Dietary Approaches to Stop Hypertension (DASH), according to researchers.

Kamlesh Khunti In the Journals

Hypoglycemia increased risks for CV events, death in patients with diabetes on insulin

December 15, 2014
Insulin-treated patients with diabetes who experience hypoglycemia are also more likely to experience cardiovascular events and die from any cause, according to research…
In the Journals

Higher insulin dosage for type 2 diabetes may increase mortality risk

December 10, 2014
Patients with type 2 diabetes taking exogenous insulin could be at increased risk for death from all causes, major adverse cardiovascular events and cancer with…
Steven Grover In the Journals

Life expectancy, healthy years likely to diminish with obesity-related diabetes, CVD

December 4, 2014
Obesity could reduce life expectancy by up to 8 years and healthy years of life by up to 19 years due to the effects of type 2 diabetes and cardiovascular disease…
CME
Risk Management in the Cardiovascular Disease Arena

Risk Management in the Cardiovascular Disease Arena: Focus on Glycemic Control

This activity is supported by an educational grant from Genentech.

Among the multiple comorbidities and complications that are associated with type 2 diabetes mellitus (T2DM)…
More »
Meeting News Coverage Video
thumbnail for video 3857626096001

Francesco Rubino, MD: 'Converting' bariatric surgery into a diabetes intervention poses challenges

October 24, 2014
BOSTON — Converting a procedure that has been used for years as a weight-loss intervention into a treatment aimed…
More »
CME
Lipid Forum II Highlights

Lipid Forum II Highlights

This activity is supported by an educational grant from Genentech.

Risk stratification and appropriate therapies for various dyslipidemias remain difficult concepts for practitioners…
More »
Meeting News Coverage

Philip Schauer, MD, offers investigator insight into 3-year STAMPEDE results

April 6, 2014
WASHINGTON — In this video, Philip Schauer, MD, director of the Cleveland Clinic Bariatric and Metabolic Institute, outlines the 3-year…
In the Journals

Lifestyle changes reduced mortality, diabetes rate in adults with IGT

April 3, 2014
The potential for weight loss and exercise to prevent deaths from cardiovascular disease and all-causes in adults with impaired glucose tolerance is…
Meeting News CoverageVideo

Darren K. McGuire, MD, MHSc, on the 3-year STAMPEDE trial results

April 1, 2014
WASHINGTON — In this video, Darren K. McGuire, MD, MHSc, professor of internal medicine and Dallas Heart Ball Chair for research on heart…
In the Journals

Intensive BP, lipid regimens improved CVD outcomes in diabetes

March 31, 2014
Compared with combined standard treatment options, intensive blood pressure or intensive glycemia treatment alone were shown to improve major…
Meeting News CoveragePerspective

Bariatric surgery provided long-term diabetes control out to 3 years

March 31, 2014
WASHINGTON — Three-year data from the STAMPEDE trial demonstrate that significantly more obese patients with diabetes who underwent bariatric…
Meeting News CoveragePerspectivePublication Exclusive

Bariatric surgery provided long-term diabetes control out to 3 years

Cardiology Today, May 2014
WASHINGTON — Three-year data from the STAMPEDE trial demonstrate that significantly more obese patients with diabetes who underwent bariatric…
Meeting News Coverage

EXAMINE: Alogliptin showed no effect on CV mortality, HF hospitalization

March 30, 2014
WASHINGTON — Alogliptin, a dipeptidyl-peptidase IV inhibitor, was not associated with increased risk for CV mortality or hospitalization for…
Meeting News Coverage

EXAMINE: Alogliptin showed no effect on CV mortality, HF hospitalization

Cardiology Today, May 2014
WASHINGTON — Alogliptin, a dipeptidyl-peptidase IV inhibitor, was not associated with increased risk for CV mortality or hospitalization for…
In the Journals

Blood glucose measures offered little benefit for CVD risk prediction

March 25, 2014
Assessment of HbA1c values in the context of CVD risk assessment may provide little incremental benefit for the prediction of CVD risk in people…
In the Journals

Hyperglycemia at hospitalization increased risk for future diabetes in MI patients

March 14, 2014
Approximately one in six patients hospitalized for acute MI have hyperglycemia without known diabetes, and these patients are at a 2.5-fold increased…
More Headlines »
morganatic-roan